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Intravascular volume expansion has been employed successfully for treatment of ischemic stroke from 
cerebral vasospasm and from cerebrovascular occlusive disease. The physiologic mechanism responsible 
for this success has not previously been delineated in controlled experimentation. The objective of this 
investigation was to delineate the effects of cardiac output and of hemodilution in a primate model of 
focal cerebral &hernia. Two groups of anesthetized rhesus monkeys received extensive cardiovascular 
monitoring, and local cerebral blood Bow (ICBF) was determined in both ischemic and nonischemic 
brain regions by the hydrogen clearance method. Both groups were subjected to unilateraJ middle cerebral 
artery occlusion. One group then underwent blood volume expansion with Dextran 40 (cardiac output 
augmentation), and one group underwent isovolemic hemodilution with Dextran 40, cardiac output 
being maintained constant. Significant increases in 1CBF occurred in ischemic regions only and occurred 
only in response to augmentation of cardiac output. Isovolemic hemodilution failed to produce any 
changes in ICBF. This investigation indicates that ischemic brain regions are selectively vulnerable to 
alterations in cardiac output, these effects being independent of alterations in blood pressure. Blood 
viscosity changes may play only a minor role. This study strongly suggests an important role of intravascular 
volume expansion and cardiac output augmentation in treatment of acute ischemic stroke. @ 1985 
Academic Press, Inc. 
INTRODUCTION 
Intravascular volume expansion has be- 
come a widely employed and highly successful 
adjunct to treatment of the ischemic syndrome 
from cerebral vasospasm in patients with sub- 
arachnoid hemorrhage from ruptured intra- 
cranial aneurysms [ 12, 13, 18, 191. Volume 
expansion with colloid agents has also been 
successful in a number of preliminary clinical 
trials on patients with acute ischemic stroke 
of occlusive origin from atheromatous cere- 
brovascular disease [ 18, 20, 291. How an in- 
crease in circulating blood volume alone 
should be successful in elevating blood flow 
to ischemic brain regions is perplexing since 
an increase in systemic arterial pressure often 
did not occur with such treatment [ 18, 191. 
Some investigators have speculated that 
blood viscosity alterations which occur when 
blood volume is expanded with various colloid 
agents could be responsible for rheologic 
changes to ischemic brain and have, therefore, 
used this theory as a rationale for their treat- 
ment [4, 7-9, 25, 29-311. However, other in- 
vestigators have suggested that cardiac output 
changes occurring with intravascular volume 
expansion and with other pharmacologic in- 
tervention during cerebral &hernia might be 
responsible for the success of this treatment 
[ 19, 20, 22, 321. It is well known that acute 
blood volume expansion produces a hyper- 
dynamic cardiovascular response, often with 
marked increases in cardiac output as would 
be predicted by the Frank-Starling law gov- 
erning cardiac function [6, 211. Why an aug- 
mentation of cardiac output alone should 
cause an increase in blood flow to ischemic 
brain regions was confusing since it was un- 
clear where cardiac output should fit into clas- 
sic equations governing cerebral blood flow. 
If ischemic brain regions were that sensitive 
to alterations in cardiac output, however, the 
implications for treatment of acute ischemic 
stroke from many causes could be quite pro- 
found. 
This study was undertaken to investigate the 
effects of intravascular volume expansion with 
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a colloid agent on cardiac output and on local 
blood flow to both ischemic and nonischemic 
brain regions in a primate model of focal ce- 
rebral &hernia. Control studies were included 
in an attempt to separate the effects of cardiac 
output changes from those of blood viscosity 
alterations alone on local cerebral blood flow 
in this model. 
METHODS 
General animal preparation and monitoring 
procedures. Adult rhesus monkeys (Macaca 
mulatta) of both sexes were utilized during the 
course of the experimental procedures. All an- 
imals were initially sedated with intramuscular 
ketamine hydrochloride (10 mg/kg) to facili- 
tate endotracheal intubation and placement 
of a peripheral intravenous catheter. Body 
temperature was maintained constant with a 
heating pad wrapped about the animal’s torso. 
Following intravenous induction of sodium 
pentobarbital anesthesia (20 mg/kg), all ani- 
mals were pharmacologically paralyzed with 
pancuronium (0.1 mg/kg) and were ventilated 
with a volume respirator using a gas mixture 
composed of 40% oxygen, 60% nitrogen. Ven- 
tilatory parameters were adjusted to maintain 
a stable pCO2 between 35 and 40 mm Hg. 
Bilateral femoral cutdowns were performed 
for placement of an arterial catheter and a long 
16-gauge catheter for central venous pressure 
monitoring and for injection of dye for cardiac 
output determinations. A 5 French double-lu- 
men flow-directed catheter was then floated 
into the pulmonary artery via the other fem- 
oral vein for continuous pulmonary arterial 
pressure recordings and for intermittent pul- 
monary arterial wedge pressure recordings. 
EKG, systemic arterial pressure, pulmonary 
arterial pressure, heart rate, and rectal tem- 
perature were continuously monitored on a 
paper strip recorder. Arterial blood gases and 
hematocrit were determined intermittently 
throughout all studies by sampling from the 
aortic catheter. Cardiac output determinations 
were performed with the use of an electronic 
cardiac output computer utilizing the dye di- 
lution method. 
Intravascular volume expansion with Dex- 
tran 40. Following baseline cardiovascular pa- 
rameter recordings and hematocrit determi- 
nations, those animals underwent incremental 
blood volume expansion with 20 to 50 ml bo- 
luses of 10% Dextran 40 which had been 
warmed in a water bath to 37°C. Several min- 
utes following each injection, repeat cardiac 
output and hematocrit determinations were 
obtained. Additional boluses of dextran were 
given at 30-min intervals until cardiac output 
plateaued at its highest level for each animal. 
Isovolemic hemodilution with Dextran 40. 
Following baseline hematocrit and cardiac 
output determinations, an exchange transfu- 
sion technique was employed in which 10% 
Dextran 40 was injected into the central ve- 
nous line while arterial blood was withdrawn 
at a similar rate through the aortic catheter. 
Equivalent volumes of dextran and whole 
blood were thereby determined in a “trial and 
error” fashion such that cardiac output would 
remain at or near control values. Cardiac out- 
put and hematocrit determinations were per- 
formed after each exchange transfusion. 
Local CBF determinations. All animals 
employed in the definitive studies on cerebral 
ischemia underwent placement of four burr 
holes in standard cranial locations following 
reflection of the scalp and temporalis muscles 
(Fig. 1). Electrodes for hydrogen clearance de- 
termination were fashioned from No. 30 plat- 
inum wire having a diameter of 0.254 mm, 
such that a bared tip of 1.5 to 2.0 mm preceded 
an insulating ball of adhesive material. The 
dura mater in each location of CBF determi- 
nation was punctured with the electrode until 
the insulating ball rested on the surface of the 
dura mater. 
The hydrogen clearance method for deter- 
minations of cerebral blood flow was em- 
ployed according to the technique and instru- 
mentation of Willis et al. [28] and each deter- 
mination was preceded by the delivery of 8 to 
10% hydrogen into the inspired gas mixture 
until tissue saturation appeared. 
Standard sites for determination of 1CBF 
are illustrated in Fig. 1. The two nonischemic 
regions selected were the left frontal convexity 
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FIG. 1. Areas for measurement of local cerebral blood 
flow. 
(contralateral hemisphere) and the right para- 
sagittal frontal region, an area supplied pre- 
dominantly by the anterior cerebral artery. 
Two areas within the distribution of the right 
middle cerebral artery (MCA) were also se- 
lected, one in the frontal opercular region and 
one in the frontal convexity region. These two 
ischemic regions were studied to delineate any 
differential responses within the middle cere- 
bral artery territory since the experiments of 
Symon et al. [27], had documented differential 
reductions in blood flow in these two locations 
in response to MCA occlusion. 
1CBF determinations were performed in 
both experimental and control animals prior 
to MCA occlusion, following MCA occlusion, 
and following each dextran bolus or each ex- 
change transfusion of dextran and blood. 
MCA exposure and occlusion. A transorbital 
technique [ lo] was performed for exposure of 
the right middle cerebral artery, using micro- 
surgical technique. At the appropriate time, 
this artery was occluded at its origin with an 
aneurysm clip. Following MCA occlusion, the 
orbit was packed loosely with saline-moistened 
cotton balls. 
Examination of brains. At the conclusion 
of each experimental or control study involv- 
ing cerebral ischemia, the animal was sacri- 
ficed with an overdosage of barbiturate. The 
brains were removed, and all were inspected 
to ensure adequacy of right middle cerebral 
artery occlusion and to inspect areas of elec- 
trode placement. All brains were preserved in 
formaldehyde and were later grossly inspected 
with coronal slicing. 
Statistical analysis of results. Local CBF 
data and cardiovascular data were compiled, 
and the means and standard deviations of each 
group were computed. Comparisons of data 
within each group and between the two groups 
were made using a two-tailed t test. 
RESULTS 
Intravascular Volume Expansion with 
Dextran 40-Circulatory Efects 
Data in Table 1 display that incremental 
volume expansion with intravenous boluses 
of Dextran 40 could be performed rather con- 
sistently without any significant alterations in 
mean arterial pressure (less than 10%). Each 
dextran bolus was promptly followed by an 
increase in cardiac output and by an increase 
in pulmonary arterial wedge pressure. He- 
matocrit steadily decreased, as would be ex- 
pected, throughout the course of volume ex- 
pansion. Cardiac output continued to rise with 
each dextran bolus until a maximal level was 
reached. Increases in cardiac output were ap- 
parently mediated by an increase in stroke 
volume in all animals since heart rate usually 
remained stable or fell slightly during volume 
expansion. The amount of dextran required 
in these animals to maximize cardiac output 
averaged 25 ml/kg. Cardiac output was also 
observed to maximize between pulmonary 
wedge pressures of 12 to 24 mm Hg with a 
mean of 17 mm Hg. 
Isovolemic Hemodilution-Circulatory 
E&cts 
Control animals in this study underwent 
exchange transfusions of equivalent volumes 
of Dextran 40 and whole blood. Thus, a state 
of isovolemic hemodilution could be achieved 
in which cardiac output would remain con- 
stant, though hemodilution to levels similar 
to those achieved in experimental animals 
would be produced. This state could be pro- 
duced by simultaneous infusion of 1 vol dex- 
tran and withdrawal of 2 vol whole blood. 
Cardiovascular data for control animals are 
also displayed in Table 1. Mean arterial pres- 
sure also remained stable in individual control 
animal studies. However, the mean arterial 
pressure on the average was significantly lower 
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TABLE 1 
CARDIOVASCULAREFFECXXEXPERIMENTALVS CONTROLANIMALS 
Intravascular volume expansion Isovolemic hemodilution 
(experimentai) n = 4 (control) n = 4 
% Increase in stroke volume 221 + 90 21 + 26 
% Increase in cardiac output 187 + 61 22 * 22 
% Decrease in hematocrit 15Ifr 5 15 + 4 
Dextran required for maximal 
cardiac output (ml/kg) 25+ 9 - 
Exchange ratio for isovolemic hemodilution 
(blood wd/dextran infused) - 2.0 + 0.3 
Pulmonary wedge pressure at maximal cardiac 
output (mm Hg) i6? 4 - 
Mean arterial pressure (mm Hg) 
Baseline 106 f  27 
At max c/o or max hemodilution 110+29 I 
86 + 6 
NS NS 
85 It 12 
Heart rate (beats/mm) 
Baseline 
At max c/o or max hemodilution 
203 k 14 
181 f  22 r 
216 +29 
NS NS 
209 * 20 
in this control group than for the experimental 
group. Cardiac output remained near prehe- 
modilution levels throughout the course of the 
experiments. Mean decrease in hematocrit was 
identical to that seen in experimental animals. 
Two control animals underwent reinfusion 
of withdrawn heparinized blood after maximal 
hemodilution, and it was noted that cardiac 
output would then tend to increase after these 
infusions. 
Unilateral MCA Occlusion-Eflect on 
Local CBF 
Preocclusion values of local blood flow were 
high in all areas measured and were certainly 
within the range of gray matter blood flow val- 
ues which have been previously reported [27]. 
Immediately following clip occlusion of the 
right middle cerebral artery, local blood flow 
fell markedly in the right frontal convexity and 
in the right frontal opercular region. Reduc- 
tions in local CBF were usually of similar 
magnitude in these two areas as displayed in 
Tables 2 and 3. Local CBF in the right frontal 
convexity fell to 41 ? 5% and to 44 & 20% of 
preocclusion values in experimental and con- 
trol animals, respectively. Local CBF in the 
right frontal opercular region fell to 45 f 12% 
and to 38 + 23% in experimental and control 
animals, respectively. Statistical analysis re- 
veals no significant differences in the depth of 
ischemia for the two groups. Responses of in- 
dividual animals in both experimental and 
control groups can be seen in Figs. 2 and 3. 
Local CBF to the contralateral hemisphere and 
to the ipsilateral parasagittal region was little 
altered by MCA occlusion. 
Intravascular Volume Expansion-Efects of 
Cardiac Output Augmentation 
on Local CBF 
The effects of intravascular volume expan- 
sion on local CBF following right MCA oc- 
clusion for each experimental animal are 
charted in Fig. 2. During the course of volume 
expansion with dextran, blood flow to non- 
ischemic regions (a and b) remained relatively 
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TABLE 2 
LOCAL CBF-EFFECT OFRIGHTMCAOCCLUSIONANDINTW\VA.SWLARVOLUMEEXPANSION 
Volume expansion 
Postocclusion maximal cardiac output 
Region Preocclusion Local CBF % Preoccl. Local CBF % Preoccl. 
Left frontal convexity 
(a) N = 4 65 + 25 67 k 26 103-t 6 78 + 31 119 i 13 
Right parasagittal 
(b) N = 4 56+ 18 55 * 19 98k I 63 + 23 112f 11 
Right frontal convexity 
(c) N = 4 39+ 13 16+ I 41f 5 24k 8 62 + 24 
P = 0.006 
Right frontal operculum 
(d) N = 4 77 +_ 36 34i 15 45 + 12 54 rt_ 24 7Ok 12 
P = 0.04 P = 0.04 
Note. Local CBF expressed as mean in ml/lOOg/min + standard deviation. 
there was usually a steady, step-wise increase 
in local CBF to ischemic regions (c and d). 
The responses of the two ischemic regions was 
variable, and the opercular region’s blood flow 
tended to increase most consistently and most 
dramatically with progressive volume expan- 
sion. 
Particularly interesting responses occurred 
late in the course of volume expansion in three 
experimental animals. Experimental monkeys 
1 and 2 apparently experienced degrees of 
congestive heart failure since a drop in cardiac 
output occurred in congress with progressive 
elevation of pulmonary wedge pressure. This 
drop in cardiac output was especially marked 
in experimental animal 2. Local CBF to isch- 
emit regions fell markedly while there were 
no changes in local CBF to nonischemic re- 
gions. This animal was given 2 mg of furose- 
mide intravenously, and there was prompt 
elevation of cardiac output and lowering of 
pulmonary wedge pressure associated with a 
brisk diuresis. While local CBF in nonischemic 
regions remained unaltered, there was a 
prompt restoration of improved blood flow to 
both ischemic regions. Experimental animal 
4 had a spontaneous large diuresis when vol- 
ume expansion with dextran was delayed. 
Both pulmonary wedge pressure and cardiac 
output fell significantly at this point as did 
1CBF to both ischemic regions. 
Compiled local CBF data for all experi- 
mental animals is displayed in Table 2. Over- 
all, local CBF tended to rise in all regions, 
though most markedly in ischemic regions. 
Blood flow to the right frontal convexity in- 
creased from 41 + 5% of preocclusion values 
to 62 + 24% at maximal cardiac output during 
volume expansion. This difference, however, 
was not statistically significant due to the in- 
consistency of responses in this region with a 
resultant large standard deviation. These dif- 
ferences in the ischemic frontal operculum, 
however, were statistically significant with an 
FIG. 2. Responses of local cerebral blood IIow (ICBF) to right middle cerebral artery (MCA) occlusion 
and intravascular volume expansion with Dextran 40. 1CBF expressed as percentage (%) of preocclusion 
value; CO, cardiac output, expressed as titers per minute (l/min); PAWP, pulmonary arterial wedge pressure; 
MABP, mean arterial blood pressure; Hct, hematocrit; (a) left frontal convexity; (b) right parasagittal region; 
(c) right frontal convexity; (d) right frontal operculum. 
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impressive increase in local CBF from 45 
-t 12% of its preocclusion value to 70 2 12% 
at maximal cardiac performance. Differences 
in local CBF to nonischemic regions were not 
statistically significant. 
Isovolemic Hemodilution-Efects on Local 
CBF with Constant Cardiac Output 
Figure 3 illustrates the course of events for 
the four control monkeys which underwent 
exchange transfusions of dextran and blood 
with resultant hemodilution at a constant car- 
diac output. Stable pulmonary wedge pres- 
sures during hemodilution reflected the stable 
volume status. Local CBF in all regions re- 
mained essentially unchanged throughout the 
course of hemodilution. At the conclusion of 
the hemodilution period, control animals 1 
and 2 underwent reinfusion of their own hep- 
arinized blood which had previously been 
withdrawn. Significant elevations in cardiac 
output occurred in response to blood reinfu- 
sions, and increases in local CBF to ischemic 
regions occurred as well. 
Compiled data for all control animals are 
presented in Table 3. While there were slight, 
but insignificant increases in local CBF to 
nonischemic regions, there were essentially no 
changes in local CBF to ischemic regions at 
maximal hemodilution. 
Comparison of Experimental and 
Control Data 
Mean percentage changes in local CBF from 
postocclusive values for both experimental and 
control animals is presented in Table 4. While 
small increases in local CBF of less than 20% 
were observed in nonischemic regions in both 
groups of animals, there were relatively large 
mean percentage increases in local CBF to 
both ischemic regions in response to volume 
expansion at maximal cardiac performance. 
There were not, however, any such increases 
in local CBF to ischemic regions seen in re- 
sponse to hemodilution without an elevation 
of cardiac output. The apparent wide differ- 
ence in local CBF response in the frontal con- 
vexity was not statistically significant due to 
inconsistency of responses seen in experimen- 
tal animals. A very high statistical significance 
could be given to the differences in local CBF 
responses in the ischemic frontal operculum, 
however. 
These observations tend to support the hy- 
pothesis that intravascular volume expansion 
can selectively increase local CBF to ischemic 
brain regions. This response appears to be 
most dependent on the augmentation of car- 
diac output which occurs from infusion of a 
colloid agent and does not occur if hemodi- 
lution without volume expansion is per- 
formed. Therefore, it appears that blood vis- 
cosity alterations occurring with hemodilution 
may play a minor role in regulation of local 
blood flow to ischemic brain. Local CBF to 
nonischemic brain is little affected by hemo- 
dilution whether or not it is performed with 
an expansion of blood volume. 
Postmortem Examination of Brains 
In all experimental and control animals, 
gross examination of brains confirmed com- 
plete clip occlusion of the right middle cerebral 
artery at its origin from the carotid bifurcation. 
Findings in coronal sectioning of brains were 
similar in all experimental and control ani- 
mals. There was minimal (less than 0.5 mm) 
or no shift of midline structures, and in ex- 
perimental monkey 1, there was mild defor- 
mity of the right lateral ventricle. The only 
discernible difference between the two groups 
of brains was a more striking pallor of the 
striate nuclei on the right seen in brains of all 
control animals. These minimal gross patho- 
FIG. 3. Responses of local cerebral blood flow (ICBF) to right middle cerebral artery (MCA) occlusion 
and isovolemic hemodilution with Dextran 4O.lCBF expressed as percentage (%) of preocclusion value; CO, 
cardiac output, expressed as liters per minute (l/min); PAWP, pulmonary arterial wedge pressure; MABP, 
mean arterial blood pressure; Hct, hematccrit; (a) left frontal convexity; (b) right parasagittal region; (c) 
right frontal convexity; (d) right frontal operculum. 
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TABLE 3 
LQCAL CBF-EFFECT OF RIGHT MCA OCCLUSION AND ISOVOLEMIC HEMODILUTION 
Region Preocclusion 
Postocclusion 
Local CBF % Preoccl. 
Maximal hemodilution 
cardiac output constant 
Local CBF % Preoccl. 
Left frontal convexity 
(a) N = 4 
Right parasagittal 
(b) N = 4 
Right frontal convexity 
(c) N = 4 
Right frontal operculum 
(d) N = 4 
62 + 34 54 + 34 85+ 8 62 + 34 101 f  28 
64f31 56 + 35 85 + 13 58 f  38 90 * 21 
49f 19 202 I 44 f  20 19+ I 45 It 27 
P = 0.05 
75 f  25 26+ 12 38 f  23 23+ I1 33 f  22 
P = 0.04 
Note. Local CBF expressed as mean in ml/100 g min f  standard deviation. 
logic findings are what would be expected from 
a relatively short duration of ischemia varying 
between 3 and 6 hr in these studies. 
DISCUSSION 
The efficacy of intravascular volume ex- 
pansion in the acute reversal of neurologic def- 
icits in patients with focal cerebral ischemia 
has been reported in multiple clinical series 
[ 12, 13, 18, 191. Several laboratory investiga- 
tions have also confirmed that volume expan- 
TABLE 4 
MEAN % CHANGE IN POST~IXLUSIVE ICBF 
Volume expansion Hemodilution 
maximal cardiac cardiac output 
output constant 




Right parasagittal +159b +5% 
(‘3 NS 




Right frontal operculum 
(d) 
+60% -11% 
P = 0.002 
sion with a colloid agent is capable of selec- 
tively increasing local blood flow to ischemic 
brain regions in both animals [ 16, 18, 301 and 
humans [9] and of reducing infarct size in an- 
imals [4, 14, 251. However, other laboratory 
models have failed to uphold any beneficial 
effect of this therapy [ 17, 231. 
A possible mechanism by which intravas- 
cular volume expansion alone, without a con- 
comitant increase in cerebral perfusion pres- 
sure, could produce an improvement in blood 
flow to ischemic brain regions has not been 
clearly delineated in the past. The usual as- 
sumption has been that hemodilution and vis- 
cosity reduction brought about by infusion of 
colloid agents such as serum albumin, low 
molecular weight dextran, mannitol, and 
glycerol improves blood flow to ischemic re- 
gions by reducing aggregation of blood ele- 
ments and by retarding intravascular “sludg- 
ing” in such low flow areas [4, 8, 9, 25, 30, 
3 11. It has also been proposed that the dehy- 
drating action of some of these agents may 
diminish perifocal edema and thereby bring 
about reductions in vascular resistance [25]. 
Neither of these theories, however, has been 
confirmed in strictly controlled laboratory in- 
vestigations. 
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Other investigators, however, have sug- 
gested that primary improvement in cardiac 
function which occurs during volume expan- 
sion with colloid agents may be responsible 
for the apparent beneficial results [ 19,20,22]. 
Patients with focal cerebral ischemia have also 
reportedly displayed neurologic improvement 
following bolstering of cardiac function with 
chronotropic [24, 321 and inotropic [3, 15,241 
agents and with therapeutic reversal of 
congestive heart failure [20], though detailed 
investigations of cardiac function were seldom 
carried out in these patients. These observa- 
tions on cardiac function and its possible re- 
lationship to cerebral perfusion prompted us 
to perform this controlled study in which we 
weighed the relative importance of changes in 
cardiac function with changes in blood vis- 
cosity when the colloid agent, dextran, is used 
for therapy of focal cerebral ischemia. 
The influences of cardiac output on cerebral 
blood flow in anesthetized cats was studied in 
detail by Davis and Sundt [5], and they dis- 
covered that normal brain is capable of au- 
toregulating its flow to cardiac output increases 
induced by hypervolemia with albumin. 
However, decreases in cardiac output induced 
by hypovolemia produced small but significant 
decreases in global CBF. The studies of 
McGillicuddy et al. [ 181 in monkeys also con- 
firmed that nonischemic brain is capable of 
maintaining a stable blood flow in response to 
hypervolemia induced by dextran infusion. 
The results of our study suggest that blood flow 
to nonischemic brain remains stable both in 
response to cardiac output augmentation with 
hypervolemia and to isovolemic hemodilu- 
tion. 
Several animal and human studies have in- 
vestigated the response of ischemic brain to 
administration of colloid agents. Cyrus et al. 
[4] performed a series of controlled experi- 
ments in dogs which underwent a 2-hr MCA 
occlusion and found that animals which were 
given large doses of intravenous 10% Dextran 
40 (15 ml/kg) prior to occlusion experienced 
much smaller areas of infarction and minimal 
neurological damage when compared to ani- 
mals which received no treatment. These in- 
vestigators attributed their results to preven- 
tion of microcirculatory obstruction from 
dextran’s hypothetical “anti-sludging” effects. 
McGillicuddy et al. [ 181 found that infusions 
of dextran following induction of vasospasm 
in the middle cerebral artery in monkeys 
brought about increases in local CBF to the 
ischemic brain region, though not to a non- 
ischemic one. Heiss [9] reported that dextran 
infusion in humans could bring about selective 
increases in regional CBF to ischemic brain 
regions while blood flow is decreased to non- 
ischemic regions. In another study, dextran 
infusion after periods of total circulatory arrest 
in dogs appeared to improve local CBF and 
EEG recovery [ 161. 
The concept of beneficial effect of hemo- 
dilution caused by administration of colloid 
solutions in cerebral ischemia was expounded 
by the report of Wood et al. [30]. They found 
that an area of focal cerebral ischemia in dogs 
responded to infusions of plasma and of dex- 
tran with significant increases in local CBF. 
Mean infarct size was also dramatically re- 
duced in animals undergoing volume expan- 
sion with these colloid agents. Autologous 
whole blood infusions failed to produce either 
significant changes in local CBF to ischemic 
regions or reduction of infarct size, however 
[30, 3 11. They concluded that “hypervolemic 
hemodilution” was the mechanism responsi- 
ble for these beneficial results. Cardiac output 
was increased in all dogs undergoing volume 
expansion, though much less so in those 
treated with whole blood transfusions (+5 8%) 
than in those receiving plasma (+ lOO%), or 
dextran (+ 114%). These authors tended to ig- 
nore the relative contribution of cardiac out- 
put to their observed results and instead pos- 
tulated a direct effect of lowered blood viscos- 
ity on local CBF despite the fact that no strict 
control studies involving hemodilution with- 
out changes in cardiac output were performed. 
Our study tends to show that cardiac output 
augmentation, rather than hemodilution and 
lowered blood viscosity alone is the most im- 
portant factor in producing the observed ef- 
fects on local blood flow to ischemic brain re- 
gions when intravascular volume expansion 
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with colloid is employed. How volume expan- 
sion with cardiac output augmentation are 
able to achieve these results remains to be elu- 
cidated, though it stands to reason that col- 
lateral circulation to the area of brain normally 
supplied by an occluded artery is somehow 
augmented when systemic circulatory activity 
is increased. Perhaps vascular resistance in 
these collateral vessels is lowered as it is in 
other organs of the body when cardiac output 
is increased by intravascular volume expan- 
sion. An autoregulating vascular bed is capable 
of resisting changes in cardiac output, but it 
is possible that areas with impaired autoreg- 
ulation in the periphery of an ischemic focus 
are unable to resist such changes in cardiac 
output, just as they are unable to resist changes 
in perfusion pressure [26]. Lowering of cardiac 
output occurring with diuresis or with the 
production of congestive heart failure in our 
studies brought about selective decreases in 
local blood flow to ischemic regions, and im- 
provement of cardiac output with appropriate 
medical treatment brought about prompt re- 
covery of blood flow to these regions. Hema- 
tocrit was not significantly changed during 
these episodes so it would be difficult to ascribe 
these changes to an alteration in blood vis- 
cosity. Pritz and Kindt [20] reported one pa- 
tient with cerebrovascular disease whose clin- 
ical status seemed to vary directly with cardiac 
status, his condition deteriorating at low car- 
diac output states occurring with extremes of 
hydration, i.e., hypovolemia and congestive 
heart failure. 
Our animals usually displayed step-wise in- 
creases in cardiac output during the course of 
volume expansion with dextran. No such step- 
wise increases in either local CBF or in cardiac 
output were observed when isovolemic he- 
modilution with dextran was employed in 
control studies. Wood et al. [3 1 ] state that the 
failure of their dogs to respond to whole blood 
infusions with significant increases in local 
CBF discounts a relationship of cardiac output 
and cerebral blood flow. However, the in- 
creases in cardiac output in their animals in 
that study and in a previous study [30] aver- 
aged only 42 and 59%. Perhaps the changes 
in local CBF in our animals at those levels of 
cardiac output increase would not have 
reached statistical significance either, but the 
progressive increase in local CBF to levels 
reached at maximal cardiac output did achieve 
statistical significance as did the results ob- 
served in the studies of Wood et al. [30] when 
cardiac output increases similar to those 
achieved in our studies (greater than 100%) 
were achieved by infusion of plasma or dex- 
tran. 
The finding of a differential response in two 
areas within an ischemic focus in our animals 
is quite interesting. Though the convexity re- 
gion often responded similarly to the opercular 
region, increases in local CBF were not as 
marked or as consistent in the convexity, this 
being reflected by a large standard deviation 
and lack of statistical significance which could 
be ascribed to the results in that area. These 
findings could be a reflection of two factors. 
Either the convexity region possesses fewer 
collaterals, or less consistent collateral circu- 
lation than does the operculum, or else the 
sample size is too small. 
The concept of “ischemic threshold” also 
deserves some comment in relation to this 
study’s results. Although many of our postoc- 
elusive local CBF values in areas of supposedly 
ischemic cortex were somewhat above the lev- 
els of I5 to 23 ml/l00 g/min (“ischemic 
threshold’ as reported in monkeys by several 
investigators [ 1,2, 11 I), areas registering post- 
occlusive blood flow below these levels usually 
responded to volume expansion with increases 
in local CBF to levels above this supposed 
“ischemic threshold.” This would imply that 
volume expansion would have therapeutic 
benefit in the eventual outcome of these ani- 
mals, although clinical neurologic status and 
infarction volumes were not observed. 
The results of our study tend to support the 
tenet that intravascular volume expansion 
may be a useful adjunct to treatment of ce- 
rebrovascular insufficiency [ 12, 18, 19, 291. 
The authors have also found this to be the 
case in a number of ischemic stroke patients 
with carotid occlusive disease, especially if 
clinical dehydration or hypovolemia is present 
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at the onset of neurologic deterioration (un- 
published data). Our finding that regions of 
focal cerebral ischemia are selectively vulner- 
able to alterations in cardiac output upholds 
the hypothesis set forth by Vander Ark and 
Pomerantz [32] and by Pritz and Kindt [20] 
that cardiac output control may be vital to 
treatment of cerebral &hernia. Primary blood 
viscosity reduction without augmentation of 
cardiac output by hypervolemia was ineffective 
in our studies and tends to discount the hy- 
pothesis set forth by other investigators that 
hemodilution per se is the primary objective 
and determinant to be followed in treatment 
of ischemic cerebrovascular disease. The rel- 
ative contribution of blood viscosity changes 
induced by colloid infusions during intravas- 
cular volume expansion will require further 
meticulous laboratory investigation. 
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